
|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
- Volume 5
- Issue 6 Suppl
Overview of Cancer Economics
Author(s)C. Daniel Mullins, PhD
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Benefits Foregone: Too Much of the Wrong and Too Little of the Rightover 26 years ago
Breast Cancer Epidemiology: An Overviewover 26 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationover 26 years ago
Question-and-Answer Sessionover 26 years ago
Selected AbstractsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
4
How Can Women Control Their Weight During Menopause?
5















































